TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36257846

Group type: EXPERIMENTAL
Intervention: Magnetic acupuncture (MA) with adhesive acupuncture magnets placed on 5 predetermined meridian points for 48 hours
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (non-magnetic adhesive metal disks placed in the same locations)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control group (no supplemental treatment)
Number of subjects: 126
Study: 33660540

Group type: EXPERIMENTAL
Intervention: Active decision making
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Prognosis
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Age and caregiving responsibilities
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Random decision-making strategies
Number of subjects: 306
Study: 32039724

Group type: EXPERIMENTAL
Intervention: Metformin (1700 and 2000 mg/d)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Metformin exposure
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Maternal testosterone and androstenedione levels
Number of subjects: 93
Study: 35470030

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 33388335

Group type: EXPERIMENTAL
Intervention: Fact-checking labels attributed to algorithms, news media, health institutions, research universities, or fact-checking organizations
Number of subjects: 1198

Group type: COMPARATOR
Intervention: Misinformation control
Number of subjects: 1198

Group type: EXPERIMENTAL
Intervention: Fact-checking labels from universities and health institutions
Number of subjects: 1198
Study: 32446470

Group type: EXPERIMENTAL
Intervention: Autodialer
Number of subjects: 84976

Group type: EXPERIMENTAL
Intervention: Text
Number of subjects: 84976

Group type: EXPERIMENTAL
Intervention: Mailed
Number of subjects: 84976

Group type: COMPARATOR
Intervention: No reminder
Number of subjects: 84976
Study: 36154809

Group type: EXPERIMENTAL
Intervention: Whole-pelvis radiotherapy (WPRT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Prostate-only radiotherapy (PORT)
Number of subjects: 69
Study: 36351721

Group type: EXPERIMENTAL
Intervention: Intranasal administration of human-derived neural stem cells (hNSCs) for 4 consecutive weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group) for 4 consecutive weeks
Number of subjects: 60
Study: 32228531

Group type: EXPERIMENTAL
Intervention: PEBRA model (peer-educator coordinated ART services)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Standard of care (ART services coordinated by the nurse)
Number of subjects: 300
Study: 35737872

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride (NaF) varnish with standard oral hygiene instructions (OHI)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: NaF plus tricalcium phosphate varnish with standard OHI
Number of subjects: 99

Group type: COMPARATOR
Intervention: Standard oral hygiene instructions (OHI)
Number of subjects: 99
Study: 34797188

Group type: EXPERIMENTAL
Intervention: Mindfulness Training (MT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Mindfulness Training (MT) + Aerobic Training (AT)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 36
Study: 32916126

Group type: EXPERIMENTAL
Intervention: Nivolumab (anti-PD-1) alone or combined with ipilimumab (anti-CTLA-4)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: IFN-γ in vitro exposure
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Conserved IFN-γ transcriptome response in melanoma cells
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Magnitude of the antitumor T cell response and corresponding downstream IFN-γ signaling
Number of subjects: 101
Study: 34261354

Group type: EXPERIMENTAL
Intervention: Inoculation with 20 μl of 10^6 conidia/ml suspensions of C. fioriniae and C. nymphaeae isolates
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sterile distilled water (control)
Number of subjects: 3
Study: 33444189

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD) including at least 6 gluten-free breads per day + 200g of gluten-free penne pasta per week + 6 rice flavour capsules per day
Number of subjects: 200

Group type: COMPARATOR
Intervention: Gluten-containing diet including at least 6 gluten-containing breads per day + 200g of gluten-containing penne pasta per week + 6 vital gluten-containing capsules per day
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 200
Study: 34406407

Group type: EXPERIMENTAL
Intervention: Weight loss and exercise (WLEX)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Weight loss (WL)
Number of subjects: 84
Study: 33784706

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation during exercise
Number of subjects: 13

Group type: COMPARATOR
Intervention: Medical air during exercise
Number of subjects: 13
Study: 32857254

Group type: EXPERIMENTAL
Intervention: Gain-framed cessation messages
Number of subjects: 135

Group type: COMPARATOR
Intervention: Loss-framed cessation messages
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Loss-framed messages
Number of subjects: 135
Study: 32798327

Group type: EXPERIMENTAL
Intervention: Diagnosis via acute services
Number of subjects: 915

Group type: COMPARATOR
Intervention: Diagnosis via other secondary care specialties
Number of subjects: 915

Group type: COMPARATOR
Intervention: Direct referral from primary care to haematology
Number of subjects: 915
Study: 36170749

Group type: EXPERIMENTAL
Intervention: mART (maternal antiretroviral therapy)
Number of subjects: 2431

Group type: COMPARATOR
Intervention: iNVP (infant nevirapine prophylaxis)
Number of subjects: 2431

Group type: EXPERIMENTAL
Intervention: mART
Number of subjects: 2431

Group type: COMPARATOR
Intervention: iNVP
Number of subjects: 2431
Study: 32956888

Group type: EXPERIMENTAL
Intervention: Telemedicine via smart glasses during virtual ward rounds
Number of subjects: 103

Group type: COMPARATOR
Intervention: Physical ward rounds conducted by resident and specialist
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Qualitative survey post-study
Number of subjects: 103
Study: 36408821

Group type: EXPERIMENTAL
Intervention: HR20033 in fasted condition
Number of subjects: 28

Group type: COMPARATOR
Intervention: HR20033 in fed condition
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Multiple oral doses of HR20033
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Both studies
Number of subjects: 28
Study: 34147377

Group type: EXPERIMENTAL
Intervention: Fermented soybean meal
Number of subjects: 13

Group type: COMPARATOR
Intervention: Non-fermented soybean meal
Number of subjects: 13
Study: 35908731

Group type: EXPERIMENTAL
Intervention: Cytisine plus counselling
Number of subjects: 869

Group type: COMPARATOR
Intervention: Counselling alone
Number of subjects: 869
Study: 33711681

Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 616084002

Group type: EXPERIMENTAL
Intervention: Laser Peripheral Iridotomy (LPI)
Number of subjects: 39
Study: 35681162

Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (including dietary intervention for the 'obesity subgroup')
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (for the 'obesity subgroup')
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Stratified exercise therapy (for the 'high muscle strength subgroup')
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: General knee OA treatment
Number of subjects: 15
Study: 33098189

Group type: EXPERIMENTAL
Intervention: Enhanced care (including use of the DecisionKEYS decision aid)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Patients with less than 20% decline in 3-IGI PRO score after two treatment cycles
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Patients with a 3-IGI decline of 20% or more
Number of subjects: 164
Study: 616083343

Group type: COMPARATOR
Intervention: Tropicamide 0.5%
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pilocarpine 1%
Number of subjects: 60
Study: 33277990

Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 85

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study: 32513226

Group type: EXPERIMENTAL
Intervention: Intensive face-to-face sessions (mean dose delivered 10.9 of 12 sessions)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Maintenance phone calls (mean dose delivered 7.7 of 9 calls)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Combination of intensive sessions (>6) and maintenance calls (>8)
Number of subjects: 610

Group type: COMPARATOR
Intervention: Control group (zero dose)
Number of subjects: 610
Study: 36478339

Group type: EXPERIMENTAL
Intervention: Learning Through Play plus Culturally adapted Cognitive Behaviour Therapy (LTP+CaCBT)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Psychoeducation (PE)
Number of subjects: 26
Study: 33880135

Group type: EXPERIMENTAL
Intervention: Intrathecal EphB2-Fc
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Intracolonic TNBS
Number of subjects: 48

Group type: COMPARATOR
Intervention: Intracolonic vehicle (control group)
Number of subjects: 48
Study: 32148330

Group type: EXPERIMENTAL
Intervention: Lumbar spinal manipulation (SMT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 80
Study: 35218193

Group type: COMPARATOR
Intervention: 2 eggs/week (control)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 7 eggs/week
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 12 eggs/week
Number of subjects: 51
Study: 33358255

Group type: EXPERIMENTAL
Intervention: Long-term cilostazol treatment
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) in the first postoperative year
Number of subjects: 249

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: High high-sensitivity chronic reactive protein level, diabetic neuropathy, sole use of an oral hypoglycemic agent, and lack of supervised exercise
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Patients without DM
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Patients with DM
Number of subjects: 249
Study: 34427052

Group type: EXPERIMENTAL
Intervention: Metformin (850 mg/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 33721199

Group type: EXPERIMENTAL
Intervention: 40 IU intranasal insulin
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: 80 IU intranasal insulin
Number of subjects: 115

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 115
Study: 32003141

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 4153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4153
Study: 35387672

Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting mortality
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Multivariate Cox regression analysis
Number of subjects: 767
Study: 34071485

Group type: EXPERIMENTAL
Intervention: Enriched yogurt with PAF inhibitors from olive pomace
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 92
Study: 34091818

Group type: EXPERIMENTAL
Intervention: 1000 Hz spinal cord stimulation
Number of subjects: 32

Group type: COMPARATOR
Intervention: 30 Hz spinal cord stimulation
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Both stimulation strategies (1000 Hz and 30 Hz)
Number of subjects: 32
Study: 32105518

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy
Number of subjects: 246

Group type: COMPARATOR
Intervention: Immediate surgery
Number of subjects: 246
Study: 35774049

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan (ARNI)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard optimal medical therapy (OMT)
Number of subjects: 106
Study: 32959589

Group type: EXPERIMENTAL
Intervention: Preoperative acupoint application therapy
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Postoperative acupoint application therapy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (ERAS interventions)
Number of subjects: 105
Study: 35738653

Group type: EXPERIMENTAL
Intervention: PCT with oNCRT
Number of subjects: 115

Group type: COMPARATOR
Intervention: PCT only
Number of subjects: 115
Study: 35679432

Group type: EXPERIMENTAL
Intervention: Vegetables only (veg‐only, n = 61)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control (fruit and vegetables, n = 56)
Number of subjects: 117
Study: 33774892

Group type: EXPERIMENTAL
Intervention: Integrative Health care (IHC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional health care (controls)
Number of subjects: 49
Study: 32727420

Group type: EXPERIMENTAL
Intervention: Usual postnatal care plus a maternal suicide prevention program (intervention group)
Number of subjects: 464

Group type: COMPARATOR
Intervention: Usual postnatal care alone (control group)
Number of subjects: 464
Study: 35737006

Group type: EXPERIMENTAL
Intervention: LLS‐TLH
Number of subjects: 80

Group type: COMPARATOR
Intervention: LSC‐TLH
Number of subjects: 80
Study: 33590850

Group type: EXPERIMENTAL
Intervention: Thymic enlargement
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Thymus attenuation score ≥ 2
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Thymus attenuation score
Number of subjects: 387
Study: 32476183

Group type: EXPERIMENTAL
Intervention: Docetaxel followed by fluorouracil, doxorubicin, and cyclophosphamide (T-FAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluorouracil, doxorubicin, and cyclophosphamide followed by docetaxel (FAC-T)
Number of subjects: 0
Study: 34570182

Group type: EXPERIMENTAL
Intervention: Whole-genome sequencing (WGS) results provided early (15 days after enrollment)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Whole-genome sequencing (WGS) results provided delayed (60 days after enrollment)
Number of subjects: 354

Group type: COMPARATOR
Intervention: Delayed group at 90 days
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Overall COMs across the observation window
Number of subjects: 354

Group type: EXPERIMENTAL
Intervention: Length of stay and survival
Number of subjects: 354
Study: 33000690

Group type: EXPERIMENTAL
Intervention: Tele‐MAST programme (n=8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care/waitlist (n=6)
Number of subjects: 14
Study: 32703800

Group type: EXPERIMENTAL
Intervention: Semiopen areas in hospitality venues
Number of subjects: 3253

Group type: EXPERIMENTAL
Intervention: Semiopen areas in higher education centres
Number of subjects: 3253

Group type: EXPERIMENTAL
Intervention: Outdoor areas in health centres
Number of subjects: 3253

Group type: EXPERIMENTAL
Intervention: Outdoor areas in schools
Number of subjects: 3253

Group type: COMPARATOR
Intervention: Enclosed areas
Number of subjects: 3253
Study: 35342752

Group type: EXPERIMENTAL
Intervention: Dycal
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: TheraCal LC
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lime-Lite
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Activa BioActive
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: RMGIC
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (no liner pretreatment)
Number of subjects: 70
Study: 33548586

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 10, received 30-45 min of training)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (n = 10, no intervention)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Experimental group (tested immediately after intervention)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Experimental group (retested one month after intervention)
Number of subjects: 20
Study: 35186238

Group type: EXPERIMENTAL
Intervention: Pericapsular nerve group block (PE group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Iliac fascia block (FI group)
Number of subjects: 48
Study: 35732390

Group type: EXPERIMENTAL
Intervention: Virtual self-conversation using the ConVRself platform
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Pre-established discourse provided by the virtual counsellor
Number of subjects: 96

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 96
Study: 33327695

Group type: EXPERIMENTAL
Intervention: Parker flex tip (PFT) ETT
Number of subjects: 58

Group type: COMPARATOR
Intervention: Unoflex reinforced (UFR) ETT
Number of subjects: 58
Study: 35286431

Group type: EXPERIMENTAL
Intervention: Humidified warm gas without forced air warming blanket (HUMI)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Humidified warm gas combined with forced air warming blanket (HUMI+)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Non-warmed, non-humidified CO2 with forced air warming blanket (AIR)
Number of subjects: 150
Study: 34436536

Group type: EXPERIMENTAL
Intervention: Everolimus (10 mg orally once daily) plus Letrozole (2.5 mg orally once daily)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Letrozole (2.5 mg orally once daily)
Number of subjects: 199
Study: 36271335

Group type: EXPERIMENTAL
Intervention: Oral esomeprazole 20 mg, twice-daily for 36 weeks (Group D)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Oral esomeprazole 20 mg, once-daily for 36 weeks (Group S)
Number of subjects: 120

Group type: COMPARATOR
Intervention: PPI-on-demand (n=32)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (Group C, n=135)
Number of subjects: 120
Study: 32174352

Group type: EXPERIMENTAL
Intervention: Non-ice-based cooling vest (PCM)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ice slushy consumed before work combined with ice-based cooling vest (SLIV)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Portable battery-operated water-perfused suit (WPS)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ice-based cooling vest (IV)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (no cooling)
Number of subjects: 8
Study: 35314817

Group type: EXPERIMENTAL
Intervention: Fortacin™ (prilocaine/lidocaine spray) - 3 sprays administered 5 min before intercourse
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Fortacin™ (prilocaine/lidocaine spray) - 3 sprays administered 15 min before intercourse
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Fortacin™ (prilocaine/lidocaine spray) - 3 sprays administered 30 min before intercourse
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Fortacin™ (prilocaine/lidocaine spray) - 1 spray administered 5 min before intercourse
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Fortacin™ (prilocaine/lidocaine spray) - 5 sprays administered 5 min before intercourse
Number of subjects: 91
Study: 33080734

Group type: EXPERIMENTAL
Intervention: Purposely seeking polyps (Group A)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Routine examination (Group B)
Number of subjects: 419

Group type: EXPERIMENTAL
Intervention: Purposely seeking polyps (Group AR-1)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Routine examination (Group BR-1)
Number of subjects: 419
Study: 35439631

Group type: EXPERIMENTAL
Intervention: Individualized aerobic training (8-week program, 30-40 min/day, 5 days/week)
Number of subjects: 140
Study: 33811367

Group type: EXPERIMENTAL
Intervention: Saroglitazar 1 mg
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Saroglitazar 2 mg
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Saroglitazar 4 mg
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 33160341

Group type: EXPERIMENTAL
Intervention: HIV prevention methods (including condoms and daily oral PrEP)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Long-acting injectable formulations (e.g., vaccines, passive antibodies, chemoprophylaxis)
Number of subjects: 38
Study: 36071005

Group type: EXPERIMENTAL
Intervention: Near-focus NBI (group A)
Number of subjects: 362

Group type: COMPARATOR
Intervention: Normal-focus NBI (group B)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: WASP criteria
Number of subjects: 362
Study: 32771456

Group type: EXPERIMENTAL
Intervention: Phaco-endocycloplasty (ECPL)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Phacotrabeculectomy
Number of subjects: 39
Study: 34164496

Group type: EXPERIMENTAL
Intervention: Fractionated frequency-doubled 1,064/532 nm picosecond Nd:YAG laser
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-ablative fractional 1,540 nm Er: glass laser
Number of subjects: 22
Study: 33389233

Group type: EXPERIMENTAL
Intervention: Spaced education alerts through the Family Medicine Study Guide mobile app
Number of subjects: 634

Group type: COMPARATOR
Intervention: Control group with the same app but no alerts
Number of subjects: 634
Study: 35256248

Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 34126630

Group type: EXPERIMENTAL
Intervention: High-dose cranberry beverage (HCb; 480 mL)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: High-dose and low-dose cranberry beverages (HCb and LCb)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Low-dose cranberry beverage (LCb; 240 mL cranberry beverage plus 240 mL placebo)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo (480 mL)
Number of subjects: 171
Study: 32576084

Group type: EXPERIMENTAL
Intervention: Abemaciclib at full dose
Number of subjects: 3843

Group type: EXPERIMENTAL
Intervention: Ribociclib at full dose
Number of subjects: 3843

Group type: EXPERIMENTAL
Intervention: Ribociclib at reduced dose (400 mg)
Number of subjects: 3843

Group type: EXPERIMENTAL
Intervention: Ribociclib at reduced dose (200 mg)
Number of subjects: 3843

Group type: COMPARATOR
Intervention: Palbociclib at full dose
Number of subjects: 3843

Group type: COMPARATOR
Intervention: Abemaciclib at reduced dose
Number of subjects: 3843

Group type: EXPERIMENTAL
Intervention: Ribociclib (overall)
Number of subjects: 3843
Study: 35273272

Group type: EXPERIMENTAL
Intervention: Unstable footwear (UF)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Stable footwear (SF)
Number of subjects: 23
Study: 33727798

Group type: COMPARATOR
Intervention: Benfotiamine (150–1200 mg single ascending doses)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Benfotiamine (150, 300, or 600 mg multiple ascending doses)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Benfotiamine
Number of subjects: 28